Valuation: Grand Pharmaceutical Group Limited

Market Cap 1.52TCr 193.94Cr 174Cr 160.87Cr 145.7Cr 272.2Cr 18TCr 275.49Cr 1.92TCr 766.13Cr 9.67TCr 727.78Cr 712.42Cr 31TCr P/E 2026 *
8.44x
P/E 2027 * 7.72x
Enterprise Value 1.52TCr 193.94Cr 174Cr 160.87Cr 145.7Cr 272.2Cr 18TCr 275.49Cr 1.92TCr 766.13Cr 9.67TCr 727.78Cr 712.42Cr 31TCr EV / Sales 2026 *
1.18x
EV / Sales 2027 * 1.08x
Free-Float
34.99%
Yield 2026 *
4.83%
Yield 2027 * 5.29%
1 day-0.80%
1 week-6.96%
Current month-11.87%
1 month-8.72%
3 months-15.63%
6 months-31.47%
Current year-44.65%
1 week 4.3
Extreme 4.305
4.57
1 month 4.3
Extreme 4.305
4.96
Current year 4.3
Extreme 4.305
8.18
1 year 4.3
Extreme 4.305
8.88
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 66 12/05/2011
Director/Board Member 62 31/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Other

Chief Executive Officer

21,500 0.0006%
22/04/26 Other

Chairman

50,000 0.0014%
21/04/26 Other

Chief Executive Officer

58,500 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%-6.96%-47.33%+5.98% 195.52Cr
+1.21%+1.85%+57.82%+128.79% 1,14300Cr
+0.96%+5.23%+45.11%+84.49% 65TCr
+0.15%+0.59%+25.90%+101.90% 51TCr
-0.05%+1.73%+52.74%+65.27% 38TCr
-0.71%-6.39%+61.22%+36.65% 35TCr
+0.34%+1.84%+30.70%+52.69% 29TCr
-0.45%+1.19%+2.89%+24.92% 26TCr
+0.78%+2.54%+53.88%+70.77% 24TCr
+0.15%+3.33%+34.61%+104.04% 20TCr
Average +0.13%+0.14%+31.75%+67.55% 40.29TCr
Weighted average by Cap. +0.45%+0.70%+44.57%+87.12%

Financials

2026 *2027 *
Net sales 1.29TCr 164.98Cr 148.02Cr 136.85Cr 123.94Cr 231.56Cr 16TCr 234.36Cr 1.64TCr 651.73Cr 8.22TCr 619.12Cr 606.05Cr 26TCr 1.41TCr 179.75Cr 161.27Cr 149.1Cr 135.04Cr 252.28Cr 17TCr 255.33Cr 1.78TCr 710.07Cr 8.96TCr 674.53Cr 660.29Cr 28TCr
Net income 182.65Cr 23Cr 21Cr 19Cr 17Cr 33Cr 2.22TCr 33Cr 230.9Cr 92Cr 1.16TCr 87Cr 86Cr 3.68TCr 199.1Cr 25Cr 23Cr 21Cr 19Cr 36Cr 2.42TCr 36Cr 251.69Cr 100.25Cr 1.26TCr 95Cr 93Cr 4.02TCr
Net Debt - -
Projected Income Statement - Annual - Grand Pharmaceutical Group Limited
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
28/26/28 HK$4.345 -0.80% 31,95,210
27/26/27 HK$4.380 -1.13% 38,79,500
26/26/26 HK$4.430 -0.56% 31,82,000
23/26/23 HK$4.455 +1.14% 18,09,000
22/26/22 HK$4.405 -3.72% 56,72,500
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Grand Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.345HKD
Average target price
9.527HKD
Spread / Average Target
+119.26%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Grand Pharmaceutical Group Limited